These bacteria are primed to infect other cells and are pushed from the epithelial layer by a new mechanism that frees the Salmonella to infect other cells or be shed into the intestine.
|See a time-lapse series showing hyper-replication of Salmonella bacteria (red) in epithelial cells from two to seven hours after infection.|
The Centers for Disease Control and Prevention estimate that Salmonella infections sicken 40,000 people each year in the United States, though the actual number of infections is likely much higher because many cases are mild and not diagnosed or reported. Currently, Salmonella is the focus of an ongoing U.S. public health investigation into contaminated chicken eggs.
“Unfortunately, far too many people have experienced the debilitating effects of Salmonella, which cause disease via largely unexplained processes, including overactive inflammatory responses,” says Anthony S. Fauci, M.D., director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID). “This elegant study provides new insight into the origins of that inflammatory disease process.”
While much is known about the human infectious cycle of Salmonella, scientists have yet to understand how the bacteria escape the gut to spread infection. Epithelial cells line the outer and inner surfaces of the body, such as the skin and gut, and form a continuous protective tissue against infection. But Salmonella have learned how to live inside epithelial cells and use them for their benefit. Salmonella protect themselves within special membrane-bound compartments, called vacuoles, inside gut epithelial cells.
Using special high-resolution microscopes to view laboratory-grown human intestinal epithelial cells and laboratory mice infected with Salmonella, an NIAID research group led by Olivia Steele-Mortimer, Ph.D., in collaboration with Bruce Vallance, Ph.D., of the University of British Columbia in Vancouver, discovered a secondary population of Salmonella not confined within a vacuole, but instead moving freely inside the epithelial cells. This reservoir of Salmonella is distinct from vacuolar Salmonella. The bacteria multiply much faster; they have long tail-like projections, called flagella, used to move; and they exhibit a needle complex they use to pierce cells and inject their proteins. With these attributes, this population of Salmonella is genetically programmed to invade new cells.
The scientists observed that epithelial cells containing the hyper-replicating, invasive Salmonella are eventually pushed out of the intestinal tissue into the gut cavity, setting the Salmonella free. The mechanism used to push these Salmonella-infected cells into the body cavity resembles the natural mechanism humans use to shed dying or dead epithelial cells from their gut. The scientists believe that Salmonella have hijacked this mechanism to facilitate their own escape.
The human immune system, however, also senses that these are not normal, dying cells in the gut and triggers a response that includes release of interleukin-18, a small protein that sets off an inflammation cascade. Interleukin-18 also is prominent in chronic intestinal inflammation associated with autoimmune disorders, such as inflammatory bowel disease. The effects of interleukin-18 release provide an explanation for the acute intestinal inflammation associated with Salmonella infections.
The scientists hope their research leads to a treatment that prevents the spread of infection. They are focusing on how this specialized population of Salmonella escapes from its membrane-bound compartment to multiply and swim freely in the cell.
L Knodler et al. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proceedings of the National Academy of Sciences DOI: 10.1073/pnas.1006098107 (2010).
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.
The National Institutes of Health (NIH)—The Nation’s Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.